Advocating for rituximab as first-line treatment for NMOSD-AQP4 patients in France: Cost and efficacy considerations
| dc.rights.license | open | en_US |
| dc.contributor.author | DESCHAMPS, Romain | |
| dc.contributor.author | PAPEIX, Caroline | |
| dc.contributor.author | AYRIGNAC, Xavier | |
| dc.contributor.author | BOURRE, Bertrand | |
| dc.contributor.author | CIRON, Jonathan | |
| dc.contributor.author | COHEN, Mikael | |
| dc.contributor.author | COLLONGUES, Nicolas | |
| dc.contributor.author | DEIVA, Kumaran | |
| dc.contributor.author | DURAND DUBIEF, Françoise | |
| dc.contributor.author | LAPLAUD, David-Axel | |
| dc.contributor.author | MAILLART, Elisabeth | |
| dc.contributor.author | MICHEL, Laure | |
| dc.contributor.author | PIQUE, Julie | |
| hal.structure.identifier | Neurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB] | |
| dc.contributor.author | RUET, Aurélie | |
| dc.contributor.author | THOUVENOT, Eric | |
| dc.contributor.author | ZÉPHIR, Hélène | |
| dc.contributor.author | MARIGNIER, Romain | |
| dc.contributor.author | AUDOIN, Bertrand | |
| dc.date.accessioned | 2025-04-29T09:51:50Z | |
| dc.date.available | 2025-04-29T09:51:50Z | |
| dc.date.issued | 2024-10 | |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/206483 | |
| dc.language.iso | EN | en_US |
| dc.subject.en | Aquaporin 4 | |
| dc.subject.en | Cost-Benefit Analysis | |
| dc.subject.en | France | |
| dc.subject.en | Humans | |
| dc.subject.en | Immunologic Factors | |
| dc.subject.en | Neuromyelitis Optica | |
| dc.subject.en | Rituximab | |
| dc.subject.en | Treatment Outcome | |
| dc.title.en | Advocating for rituximab as first-line treatment for NMOSD-AQP4 patients in France: Cost and efficacy considerations | |
| dc.title.alternative | Rev Neurol | en_US |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1016/j.neurol.2024.06.003 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Neurosciences [q-bio.NC] | en_US |
| dc.identifier.pubmed | 38969609 | en_US |
| bordeaux.journal | Revue Neurologique | en_US |
| bordeaux.page | 711-714 | en_US |
| bordeaux.volume | 180 | en_US |
| bordeaux.hal.laboratories | Neurocentre Magendie - U1215 | en_US |
| bordeaux.issue | 8 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | INSERM | en_US |
| bordeaux.team | Relations glie-neurone | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.identifier.funderID | Agence Nationale de la Recherche | en_US |
| bordeaux.identifier.funderID | Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques | en_US |
| hal.popular | non | en_US |
| hal.audience | Internationale | en_US |
| hal.export | false | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Revue%20Neurologique&rft.date=2024-10&rft.volume=180&rft.issue=8&rft.spage=711-714&rft.epage=711-714&rft.au=DESCHAMPS,%20Romain&PAPEIX,%20Caroline&AYRIGNAC,%20Xavier&BOURRE,%20Bertrand&CIRON,%20Jonathan&rft.genre=article |
Fichier(s) constituant ce document
| Fichiers | Taille | Format | Vue |
|---|---|---|---|
|
Il n'y a pas de fichiers associés à ce document. |
|||